title: AVERTing contrast nephropathy--delivering less to get more?
abstract: Delivered contrast volume is the major modifiable risk factor for contrast nephropathy. The AVERT system can divert 31-40% of contrast for peripheral angiography. The upcoming results of the AVERT clinical trial will demonstrate whether the AVERT system reduces contrast nephropathy.
authors.affiliation: Division of Cardiology, Department of Medicine, Long Beach Veterans Affairs Medical Center, University of California, Irvine Medical Center, Long Beach, California.
authors.forename: Arnold H
authors.initials: AH
authors.lastname: Seto
authors.affiliation: Division of Cardiology, Department of Medicine, Long Beach Veterans Affairs Medical Center, University of California, Irvine Medical Center, Long Beach, California.
authors.forename: Morton J
authors.initials: MJ
authors.lastname: Kern
mesh_terms: D000792:Angiography; D003287:Contrast Media; D017023:Coronary Angiography; D003404:Creatinine; D006801:Humans; D007674:Kidney Diseases; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D003287:Contrast Media; D003404:Creatinine